Study Pharmacy Abroad 2026: MPharm UK, PharmD USA/Canada, OSPAP, GPhC, AHPRA — Complete Guide with Costs in INR and NGN
By AnyUni Team · Updated 2 November 2026
Pharmacy is a highly regulated profession globally — a pharmacy degree from Nigeria, India, or the Philippines does not automatically qualify you to practice in the UK, USA, Canada, or Australia. Each destination has its own registration pathway, qualifying exam, and supervised practice requirement. However, the demand for pharmacists in all four English-speaking destination countries is extremely high — all have pharmacist shortages, and pharmacy appears on shortage occupation or immigration priority lists in multiple countries. This guide covers the full pathway: studying for an MPharm or PharmD abroad, the OSPAP route for internationally qualified pharmacists seeking UK practice, GPhC (UK pharmacy regulator) registration, AHPRA (Australian pharmacy regulator) registration, and salary expectations in each country — all costs in INR and NGN so Indian and Nigerian students can compare directly.
MPharm in the UK — Top Universities, Costs, and Programme Structure
The Master of Pharmacy (MPharm) is the entry-level pharmacy qualification in the UK — a 4-year integrated master's degree required to register as a pharmacist with the General Pharmaceutical Council (GPhC). As of 2026, the MPharm is transitioning to a new 5-year integrated programme (including 1-year pre-registration training, which the new curriculum embeds within the degree). International students can study for the MPharm at most Russell Group and pharmacy schools across the UK.
Top UK MPharm Programmes:
- Duration: 4 years (MPharm); transitioning to 5-year with embedded pre-reg
- Annual tuition (international): GBP 28,000–30,000 = INR 29,40,000–31,50,000 = NGN 56,000,000–60,000,000
- Location: Bloomsbury, London (UCL central campus)
- Strengths: research-intensive; clinical pharmacy track strong; excellent industry connections in London
- Entry requirements: A-levels Chemistry + Biology (or equivalent); GPA 3.8/4.0+ equivalent; GCSE Mathematics and English at grade C/5+
- University IELTS: 7.0 overall (6.5 per band minimum)
- Total 4-year cost (tuition only): GBP 112,000–120,000 = INR 1,17,60,000–1,26,00,000 = NGN 224,000,000–240,000,000
- Duration: 4 years (MPharm)
- Annual tuition (international): GBP 27,000–28,500 = INR 28,35,000–29,92,500 = NGN 54,000,000–57,000,000
- Location: Denmark Hill campus (South London, near King's College Hospital — excellent clinical exposure)
- Strengths: clinical pharmacy, hospital pharmacy placements at King's NHS Foundation Trust; pharmacy practice research
- Total 4-year cost (tuition only): GBP 108,000–114,000 = INR 1,13,40,000–1,19,70,000 = NGN 216,000,000–228,000,000
- Duration: 4 years (MPharm)
- Annual tuition (international): GBP 26,500–28,000 = INR 27,82,500–29,40,000 = NGN 53,000,000–56,000,000
- Location: Manchester (lower living costs than London — significant saving on total budget)
- Strengths: strong pharmaceutical sciences; industrial pharmacy and drug discovery research links with AstraZeneca and other major pharma companies based near Manchester
- Total 4-year cost (tuition only): GBP 106,000–112,000 = INR 1,11,30,000–1,17,60,000 = NGN 212,000,000–224,000,000
- Duration: 4 years (MPharm)
- Annual tuition (international): GBP 24,500–26,000 = INR 25,72,500–27,30,000 = NGN 49,000,000–52,000,000
- Location: Nottingham (lower cost of living than London or Manchester)
- Strengths: pharmaceutical sciences; pharmaceutical biotechnology; good NHS community pharmacy placement network in the East Midlands
- Total 4-year cost (tuition only): GBP 98,000–104,000 = INR 1,02,90,000–1,09,20,000 = NGN 196,000,000–208,000,000
- Duration: 4 years (MPharm)
- Annual tuition (international): GBP 18,500–20,000 = INR 19,42,500–21,00,000 = NGN 37,000,000–40,000,000
- Location: Bradford, West Yorkshire (one of the most affordable UK cities; significant Pakistani community — relevant for Pakistani students; diverse student population)
- Entry requirements: slightly lower than UCL/King's; accessible to a wider range of international students
- Total 4-year cost (tuition only): GBP 74,000–80,000 = INR 77,70,000–84,00,000 = NGN 148,000,000–160,000,000
- Note: This is significantly more affordable than UCL or King's for essentially the same MPharm qualification; GPhC accreditation is what matters for registration, not university ranking
- Duration: 4 years (MPharm)
- Annual tuition (international): GBP 23,000–25,000 = INR 24,15,000–26,25,000 = NGN 46,000,000–50,000,000
- Location: Glasgow, Scotland (lower living costs than London; excellent NHS Scotland placement network; Scotland has different tuition fees for EU/UK but same for international)
- Tuition (4 years): GBP 98,000–110,000
- Living costs (4 years in non-London city): approximately GBP 40,000–48,000 (GBP 10,000–12,000/year)
- Total all-in (non-London): GBP 138,000–158,000 = INR 1,44,90,000–1,65,90,000 = NGN 276,000,000–316,000,000
- Tuition (4 years, London): GBP 108,000–120,000
- Living costs (4 years London): approximately GBP 60,000–72,000 (GBP 15,000–18,000/year)
- Total all-in (London): GBP 168,000–192,000 = INR 1,76,40,000–2,01,60,000 = NGN 336,000,000–384,000,000
This is a large investment — but pharmacist salaries in the UK (see salary section) make it recoverable over a career.
OSPAP — The UK Route for Already-Qualified International Pharmacists
The Overseas Pharmacists Assessment Programme (OSPAP) is the GPhC-approved pathway for pharmacists who qualified outside the UK/EU to become eligible for registration as a pharmacist in Great Britain (England, Scotland, and Wales; Northern Ireland has separate PSNI regulation).
- Hold a pharmacy degree and are registered as pharmacists in their home country (India, Nigeria, Ghana, Pakistan, UAE, USA, Australia, etc.)
- Want to practice pharmacy in Great Britain without completing the full 4-year MPharm
OSPAP is NOT for:
Students who have NOT yet qualified as pharmacists. If you are a pharmacy student or recently graduated but not yet registered as a pharmacist in your home country, OSPAP is not your route — you need the full MPharm or to first register in your home country and then do OSPAP.
- You become eligible to undertake the GPhC's Initial Education and Training (IET) year (the pre-registration period, now called Foundation Training Year in the new 2026 system)
- After Foundation Training Year and passing the GPhC registration assessments, you register as a pharmacist
OSPAP provider universities and costs:
- Fee: approximately GBP 15,000–17,000 for the 1-year OSPAP programme = INR 15,75,000–17,85,000 = NGN 30,000,000–34,000,000
- Fee: approximately GBP 14,000–16,000 = INR 14,70,000–16,80,000 = NGN 28,000,000–32,000,000
- Fee: approximately GBP 13,500–15,500 = INR 14,17,500–16,27,500 = NGN 27,000,000–31,000,000
- Fee: approximately GBP 14,000–15,500 = INR 14,70,000–16,27,500 = NGN 28,000,000–31,000,000
Several other GPhC-approved OSPAP providers exist; check the GPhC website (pharmacyregulation.org) for the current list of OSPAP approved programmes.
- Pharmacy degree from an accredited institution in your home country
- Active registration as a pharmacist with your home country regulator (PCN in Nigeria; PCI in India; PSC in Ghana; PPRA in Pakistan)
- Good standing certificate from your home regulator (confirmation you are registered with no disciplinary action)
- English language proficiency: IELTS 7.0 overall (minimum 6.5 in each band), or equivalent
- Evidence of recent (typically within last 5 years) pharmacy practice
- Apply directly to OSPAP-approved universities in the UK
- Applications typically open in October/November for September start
- OSPAP is competitive — priority often given to pharmacists with hospital pharmacy, clinical pharmacy, or research experience
- Some programmes have English language tests as part of their own pre-assessment
- Complete OSPAP (1 year)
- Complete Foundation Training Year (1 year supervised practice at an approved pharmacy in the UK) — GPhC reformed the pre-registration system in 2026; the new programme integrates supervised training differently from the old system; check pharmacyregulation.org for current requirements
- Pass the GPhC registration assessments (knowledge-based assessment and practical skills assessment)
- Register with the GPhC as a pharmacist
Total OSPAP-to-GPhC-registration timeline: approximately 2 years from starting OSPAP.
OSPAP for Indian pharmacists: Indian pharmacy degrees from PCI-accredited institutions are accepted for OSPAP. India is one of the most represented nationalities among OSPAP students. B.Pharm holders may need to confirm with OSPAP-providing university whether their degree (4-year B.Pharm, equivalent to UK MPharm) meets OSPAP prerequisites — some require a minimum 4-year pharmacy degree; a 3-year B.Pharm may require additional qualifications.
OSPAP for Nigerian pharmacists: Nigerian pharmacy degrees from PCN-accredited institutions are accepted. 5-year B.Pharm from Nigerian universities (which includes the induction programme) qualifies. Nigerian pharmacists must also provide a certificate of good standing from the Pharmacists Council of Nigeria (PCN).
PharmD in the USA and Canada — Costs, Registration, and Career Pathway
PharmD in the USA:
The Doctor of Pharmacy (PharmD) is the entry-level pharmacy qualification in the USA — a 4-year doctoral programme (after a minimum 2 years of pre-pharmacy undergraduate study). To practice pharmacy in the USA, you must hold a PharmD from an ACPE-accredited programme and pass the NAPLEX (North American Pharmacist Licensure Examination) and MPJE (Multistate Pharmacy Jurisprudence Examination).
International pharmacists (already holding pharmacy degrees from their home countries) can apply for a PharmD in the USA, typically entering a bridging pathway or full PharmD programme. Unlike the UK's OSPAP model, the USA does not have a single short conversion pathway — most internationally qualified pharmacists must complete most or all of the PharmD if they want to practice in the USA.
Top PharmD programmes for international students:
- Annual tuition: USD 51,000 = INR 42,84,000 = NGN 81,600,000
- Total 4-year PharmD tuition: USD 204,000 = INR 1,71,36,000 = NGN 326,400,000
- Location: Los Angeles, CA
- Annual tuition (out-of-state/international): USD 50,000 = INR 42,00,000 = NGN 80,000,000
- Location: Ann Arbor, MI
- Annual tuition (out-of-state): USD 42,000 = INR 35,28,000 = NGN 67,200,000
- Annual tuition: USD 38,000–44,000 = INR 31,92,000–36,96,000 = NGN 60,800,000–70,400,000
- Accepts international students; higher acceptance rates than flagship state universities
- Annual tuition: USD 30,000 (in-state equivalent for in-state status seekers) / approximately USD 36,000 out-of-state
- One of the more affordable PharmD options; serves significant numbers of African and African-American students
- Tuition (4 years, mid-range): USD 160,000–200,000 = INR 1,34,40,000–1,68,00,000 = NGN 256,000,000–320,000,000
- Living costs (4 years): USD 60,000–80,000
- Total all-in: USD 220,000–280,000 = INR 1,84,80,000–2,35,20,000 = NGN 352,000,000–448,000,000
- Computer-adaptive test; 250 questions; 6 hours
- Passing score: 75 (scores range 0–150)
- Cost: USD 630 = INR 52,920 = NGN 1,008,000
- Pass rate overall: approximately 87–90% for US-educated PharmD graduates; lower for internationally educated graduates
- Entry-level community pharmacist: USD 115,000–130,000/year = INR 96,60,000–1,09,20,000/year = NGN 184,000,000–208,000,000/year
- Hospital pharmacist (clinical): USD 120,000–140,000/year = INR 1,00,80,000–1,17,60,000/year
- Pharmacist Manager / Director of Pharmacy: USD 140,000–180,000/year
- Specialty pharmacy (oncology, transplant): USD 130,000–160,000/year
Work authorization for F-1 PharmD students:
PharmD is a STEM-eligible doctorate; 36-month STEM OPT available after graduation for PharmD graduates. However, pharmacy practice in the USA requires licensure (NAPLEX + MPJE) — you need your licence to work as a pharmacist regardless of OPT status. During OPT, you can work as a pharmacy intern/pharmacist under supervision while pursuing licensure.
PharmD in Canada:
Canada's pharmacy system requires completion of a Canadian pharmacy degree (B.Sc. Pharm or PharmD from CCAPP-accredited Canadian university) or passing the Pharmacy Examining Board of Canada (PEBC) Qualifying Examinations.
- University of Toronto Leslie Dan Faculty of Pharmacy: 4-year PharmD (entry-to-practice); international tuition approximately CAD 40,000–50,000/year = INR 24,68,000–30,85,000/year = NGN 75,200,000–94,000,000/year
- University of British Columbia Faculty of Pharmaceutical Sciences: international tuition approximately CAD 36,000–44,000/year
- University of Alberta: approximately CAD 28,000–35,000/year for international students
For internationally qualified pharmacists seeking Canadian licensure without completing a full PharmD in Canada: the PEBC (Pharmacy Examining Board of Canada) has an evaluating examination (PEBC Evaluating Exam — MCQ) that assesses equivalency of international pharmacy credentials to Canadian standards. Passing the evaluating exam is the first step toward Canadian licensure. After passing: you must complete a Canadian accredited programme or have your qualifications assessed for direct licensure by the provincial pharmacy regulator.
Canadian pharmacy salary: CAD 90,000–115,000/year = INR 55,53,000–70,95,500/year = NGN 169,200,000–216,200,000/year
AHPRA Pharmacy Registration in Australia — Pathway for Indian and Nigerian Pharmacists
Australia's pharmacy regulatory system is managed by AHPRA (Australian Health Practitioner Regulation Agency) through the Pharmacy Board of Australia. Internationally qualified pharmacists seeking to practice in Australia must go through the OPEn (Overseas Pharmacists Assessment Programme) pathway.
Australian Pharmacy Pathway for International Pharmacists:
- Pharmacy degree certificate and transcripts (official, certified)
- Good standing certificate from home regulator (PCN for Nigeria; PCI for India)
- Identity documents (passport)
- English language evidence (IELTS 7.0 all bands — same standard as nursing AHPRA; this is strict)
- AHPRA application fee: approximately AUD 600 = INR 31,500 = NGN 1,200,000
- Knowledge assessment (online examination covering Australian pharmacy law, pharmacotherapy, patient counselling)
- Structured workplace assessment (supervised practice in an approved Australian pharmacy setting)
Step 3 — Supervised practice (internship):
After passing the OPEn assessment, you must complete 1,824 hours (approximately 1 year full-time) of supervised practice in an approved Australian pharmacy setting, overseen by an AHPRA-registered pharmacist supervisor.
Step 4 — Intern pharmacist registration and KAPS examination:
During supervised practice, you are registered as an intern pharmacist. The KAPS (Knowledge and Performance Assessment of Pharmacists) is the final assessment before full registration. KAPS tests clinical knowledge and practice skills.
Step 5 — Full AHPRA registration as a pharmacist:
Upon passing KAPS and completing supervised practice, AHPRA grants full registration as a pharmacist in Australia.
Total timeline for internationally qualified pharmacist to AHPRA registration: approximately 2–3 years from arrival in Australia.
English language requirement for AHPRA pharmacy:
IELTS Academic: 7.0 overall with minimum 7.0 in each band (Listening, Reading, Writing, Speaking). This is one of the most stringent English requirements in healthcare — no band can fall below 7.0. OET (Occupational English Test) is also accepted by AHPRA pharmacy: minimum Grade B in all sections.
- Community pharmacist (entry-level): AUD 65,000–75,000/year = INR 34,12,500–39,37,500/year = NGN 130,000,000–150,000,000/year
- Hospital pharmacist (clinical): AUD 75,000–95,000/year = INR 39,37,500–49,87,500/year = NGN 150,000,000–190,000,000/year
- Pharmacist Manager (community pharmacy): AUD 85,000–100,000/year
- Specialist clinical pharmacist (oncology, ICU): AUD 95,000–120,000/year
- Subclass 189 (Skilled Independent — requires positive skills assessment + points score typically 65+; no employer sponsor needed)
- Subclass 190 (State/Territory Nominated — requires state nomination; somewhat lower points hurdle)
- Subclass 491 (Regional — temporary; requires living in regional area; leads to PR after 3 years)
The positive skills assessment for pharmacy is done by the Australian Pharmacy Council (APC). Having AHPRA registration significantly supports the skills assessment process.
GPhC Registration and UK Pharmacist Salaries — NHS Band 6, 7, 8
GPhC (General Pharmaceutical Council) Registration:
The GPhC is the regulator for pharmacists, pharmacy technicians, and pharmacy premises in Great Britain (England, Scotland, Wales). Registration is mandatory to practice pharmacy in GB.
GPhC registration routes as of 2026:
- Complete a 4-year MPharm from a GPhC-accredited UK university
- Complete the Foundation Training Year (FTY) — 1 year of supervised practice in an approved pharmacy setting
- Pass the GPhC's registration assessments (as per the 2026 reformed Initial Education and Training (IET) framework)
- Apply for registration on the GPhC register
- Complete the OSPAP programme (1 year) at a GPhC-approved provider
- Complete the Foundation Training Year (1 year supervised practice)
- Pass GPhC registration assessments
- Apply for registration
Route 3 — EU/EEA qualifications (pre-Brexit recognition; this route has significantly changed post-Brexit; confirm current status with GPhC)
**GPhC registration fee (annual):
approximately GBP 288/year = INR 30,240/year = NGN 576,000/year
UK Pharmacist Salaries — NHS Bands:
NHS (National Health Service) pharmacists in England are paid under the NHS Agenda for Change (AfC) pay scales. As of 2025/2026:
- Salary range: GBP 37,338–44,962/year = INR 39,20,490–47,21,010/year = NGN 74,676,000–89,924,000/year
- Who this applies to: newly GPhC-registered pharmacists taking their first NHS hospital position; community pharmacy trainee pharmacists in NHS-equivalent roles
- Salary range: GBP 46,148–52,809/year = INR 48,45,540–55,44,945/year = NGN 92,296,000–105,618,000/year
- Who this applies to: pharmacists with 2–5 years post-registration experience; specialist clinical pharmacists in oncology, cardiology, mental health, HIV, respiratory; senior community pharmacy practitioners
- Salary range: GBP 53,755–60,504/year = INR 56,44,275–63,52,920/year = NGN 107,510,000–121,008,000/year
- Who this applies to: lead pharmacists in specialist departments; clinical pharmacy leads; deputy chief pharmacists at smaller NHS trusts
- Salary range: GBP 62,215–72,293/year+
- Director of Pharmacy at NHS trust: can reach GBP 80,000–100,000+
- Locum pharmacist rates (per day): GBP 200–350/day = INR 21,000–36,750/day = NGN 400,000–700,000/day (self-employed; locum work is highly flexible and often well-paid per day; the tradeoff is no holiday pay, pension, or job security)
- Permanent staff pharmacist (community): GBP 35,000–50,000/year depending on experience and location
London weighting:
NHS London salaries include a High Cost Area Supplement (HCAS) of approximately 20% of salary (maximum around GBP 7,000/year extra); this partially compensates for London's higher living costs.
Pharmacy on UK Shortage Occupation / Immigration Salary Threshold List:
Pharmacy is listed as a shortage occupation in England and Scotland (verify current status at the Home Office — lists change with NHS workforce updates). This has implications for Skilled Worker visa applications — some shortage occupation roles attract a 20% discount on the minimum salary threshold for Skilled Worker visas, making it easier for internationally trained pharmacists to meet the financial requirements for a UK Skilled Worker visa after completing their GPhC registration.
Community vs Hospital vs Industry Pharmacy — Which Track for International Graduates?
International pharmacy graduates in the UK, USA, Australia, and Canada face a choice between three career tracks. Each has different salary trajectories, work-life balance, and immigration implications.
Community Pharmacy:
Working in a high-street, supermarket, or neighbourhood pharmacy (Boots, Superdrug, Day Lewis, independent pharmacies in UK; CVS, Walgreens, Rite-Aid in USA; Shoppers Drug Mart in Canada; Priceline, Chemist Warehouse in Australia).
- Highest immediate patient contact
- Strong geographic flexibility (work in any town; rural pharmacies often have shortages)
- Flexible hours and shift patterns; locum work available
- Generally faster to find employment than hospital pharmacy (less competition)
- In Australia and Canada, community pharmacy can support PR pathways through regional sponsorship
Salary (UK): GBP 35,000–48,000/year for permanent staff; GBP 200–350/day locum
Salary (USA): USD 115,000–125,000/year (community pharmacy is one of the highest-paying US pharmacist roles due to Walgreens/CVS competition)
Salary (Australia): AUD 65,000–80,000/year community; AUD 80–100/hour locum
- In UK, community pharmacy sector has been under significant NHS contract pressure; many independent pharmacies closed 2018–2024; Lloydspharmacy's withdrawal from the UK market reduced available jobs
- Dispensing volume targets and commercial pressures in chain pharmacies
- Less clinical complexity compared to hospital pharmacy
Hospital/Clinical Pharmacy:
Working in an NHS hospital (UK), hospital system (USA/Canada), or public hospital (Australia) as a clinical pharmacist — providing medication review, clinical consultations, therapeutic monitoring, and multi-disciplinary team input.
- Higher clinical complexity and intellectual stimulation
- NHS pension (defined benefit — one of the best pension schemes in the world) for UK hospital pharmacists
- Clear progression pathway (Band 6 → Band 7 → Band 8a → Band 8b)
- Academic opportunities (teaching pharmacy students, research)
- More regulated hours (typically Monday–Friday with on-call rota)
Salary (UK NHS): GBP 37,000–52,000 (Band 6/7); GBP 53,000–72,000 (Band 8)
Salary (USA hospital): USD 120,000–145,000/year; clinical pharmacy specialists USD 130,000–160,000
- More competitive to enter than community pharmacy (GPhC registration alone is not sufficient; NHS hospitals want clinical pharmacy experience/rotations)
- PhD or postgraduate diploma (PGDip) in clinical pharmacy increasingly expected for Band 7+ roles
- Hospital on-call rota can include weekends and nights
Pharmaceutical Industry Pharmacy:
Working in the pharmaceutical industry (Pfizer, GSK, AstraZeneca, Roche, Novartis, MSD/Merck, Johnson & Johnson) in roles such as medical affairs, drug safety / pharmacovigilance, regulatory affairs, clinical research, or medical information.
- Highest average salary among pharmacy career tracks
- Regular office hours (no weekend dispensing, no overnight on-call)
- Commercially relevant experience valued globally
- Career progression into management/directorial roles without clinical registration constraints
- Major pharma company hubs: UK (Uxbridge, Macclesfield/Cheshire for AstraZeneca, Middlesex for GSK); USA (New Jersey, Boston, San Francisco); Australia (Sydney, Melbourne)
- Pharmacovigilance/Drug Safety Associate: GBP 35,000–45,000
- Medical Affairs Manager: GBP 60,000–85,000
- Regulatory Affairs Specialist: GBP 45,000–70,000
- Medical Information Senior Specialist: GBP 45,000–60,000
- Entry-level (Associate): USD 70,000–90,000
- Manager/Senior Manager: USD 100,000–150,000
- Director: USD 150,000–200,000+
- Most industry roles do not require active GPhC/AHPRA registration (industry does not require the professional licence for many roles) — advantage if registration pathway is complex; disadvantage if you later want to return to clinical practice
- Industry culture focuses on commercial outcomes; may not suit pharmacists who trained for patient care
- Entry to pharma industry is competitive — typically needs relevant experience or MSc/PhD background
- For the UK: OSPAP route into hospital pharmacy (Band 6) is the most structured and financially secure pathway; NHS provides stability, pension, and clear progression; community pharmacy is also accessible and can provide faster initial employment while you build UK experience
- For Australia: Community pharmacy + regional area is the best combination for PR eligibility; MLTSSL listing means you can access Subclass 189/190/491 routes; regional community pharmacy is often willing to sponsor OSPAP-equivalent/AHPRA-registered international pharmacists
- For the USA: PharmD is the most reliable but expensive route; if you are already a registered pharmacist in India or Nigeria, check whether any US state accepts foreign pharmacy credentials directly — most require FPGEE (Foreign Pharmacy Graduate Equivalency Examination) as a first step, plus NAPLEX; this path is complex and a US immigration attorney/pharmacist career advisor should be consulted before committing
Frequently Asked Questions
Free Download · 2026/2027 Edition
UK Student Visa & IELTS Waiver Checklist
43-point checklist used by 2,000+ AnyUni students — CAS letter, finances, TB test, biometrics and IELTS waiver eligibility in one PDF.
Related Reading
Make Your Decision
Free tools and guides — no consultation needed
Ready to Start Your Application?
Get matched with universities that fit your profile — free of charge.
Interested in studying pharmacy abroad or qualifying as a pharmacist in the UK or Australia? AnyUni helps pharmacy students and qualified pharmacists navigate OSPAP, GPhC, and AHPRA registration pathways. Start your journey with AnyUni.